Tsigkou Olga, Jones Julian R, Polak Julia M, Stevens Molly M
Department of Materials, Imperial College London, London, United Kingdom; Institute of Biomedical Engineering, Imperial College London, London, United Kingdom.
Biomaterials. 2009 Jul;30(21):3542-50. doi: 10.1016/j.biomaterials.2009.03.019. Epub 2009 Mar 31.
Bioactive glasses bond strongly to bone in vivo and their ionic dissolution products have previously been shown to have stimulatory properties on adult and fetal osteoblasts and to induce the differentiation of embryonic stem cells towards the osteoblastic lineage in vitro. In the present study, the effect of 45S5 Bioglass conditioned medium with two different Si concentrations (15 microg/ml (BGCM/15) and 20 microg/ml (BGCM/20)) on human fetal osteoblast growth, differentiation and extracellular matrix production and mineralization was investigated. In the first instance, primary fetal osteoblasts were examined for the osteoblast phenotypic markers alkaline phosphatase (ALP), collagen type I (Col I) and OB Cadherin (Cadherin 11) (OB Cad) as well as for the mesenchymal stem cell markers CD105 and CD166. At passage 0 more than 50% of the population was positive for Col I and ALP, but at passage 2, the proportion of cells expressing ALP increased. In addition at passage 0 more than 50% of the fetal osteoblasts expressed the mesenchymal stem cell surface markers CD105 and CD166. Treatment with BGCM/15 and BGCM/20 in the absence of osteogenic supplements increased the gene expression of the bone extracellular matrix proteins alkaline phosphatase, osteonectin and bone sialoprotein as determined by quantitative real time reverse transcriptase-polymerase chain reaction (rt RT-PCR) analysis. Extracellular matrix production was also enhanced in the absence of osteogenic supplements by the 45S5 Bioglass conditioned medium as demonstrated by ALP enzymatic activity, osteocalcin and Col I protein synthesis. Furthermore, BGCM/15 and BGCM/20 significantly enhanced the formation of mineralized nodules, based on alizarin red histochemical staining, without necessitating the addition of beta-glycerophosphate, l-ascorbate-2-phosphate or dexamethasone (commonly used osteogenic supplements).
生物活性玻璃在体内与骨紧密结合,其离子溶解产物先前已被证明对成体和胎儿成骨细胞具有刺激特性,并能在体外诱导胚胎干细胞向成骨细胞谱系分化。在本研究中,研究了含有两种不同硅浓度(15微克/毫升(BGCM/15)和20微克/毫升(BGCM/20))的45S5生物活性玻璃条件培养基对人胎儿成骨细胞生长、分化、细胞外基质产生和矿化的影响。首先,检测原代胎儿成骨细胞中成骨细胞表型标志物碱性磷酸酶(ALP)、I型胶原蛋白(Col I)和OB钙黏蛋白(钙黏蛋白11)(OB Cad)以及间充质干细胞标志物CD105和CD166。在第0代时,超过50%的细胞群Col I和ALP呈阳性,但在第2代时,表达ALP的细胞比例增加。此外,在第0代时,超过50%的胎儿成骨细胞表达间充质干细胞表面标志物CD105和CD166。在没有成骨补充剂的情况下,用BGCM/15和BGCM/20处理可增加骨细胞外基质蛋白碱性磷酸酶、骨粘连蛋白和骨唾液蛋白的基因表达,这通过定量实时逆转录聚合酶链反应(rt RT-PCR)分析确定。45S5生物活性玻璃条件培养基在没有成骨补充剂的情况下也增强了细胞外基质的产生,这通过ALP酶活性、骨钙素和Col I蛋白合成得到证明。此外,基于茜素红组织化学染色,BGCM/15和BGCM/20显著增强了矿化结节的形成,而无需添加β-甘油磷酸、l-抗坏血酸-2-磷酸或地塞米松(常用的成骨补充剂)。